A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Sponsored by Eli Lilly and Company
About this study
The main purpose of this study is to evaluate whether treatment with donanemab slows the progression of cognitive (how we think, learn, remember, pay attention, and make decisions) and functional (how we are able to perform daily activities) decline. For each participant, the study will last one and a half years.
Where this study is enrolling (30)
- I'm interested
HonorHealth Research Institute
Scottsdale, Arizona
- I'm interested
TrialSphere Corp
Chandler, Arizona
- Call 760-631-3000
Profound Research LLC
Carlsbad, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 949-753-1663
Irvine Clinical Research
Irvine, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 818-398-9855
Stanford Neuroscience Health Center
Palo Alto, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Show all 30 locations
- Call 203-914-1903
Ki Health Partners, LLc, dba New England Institute for Clinical Research
Stamford, Connecticut
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 561-968-2933
JEM Research Institute
Atlantis, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 561-845-0500
Palm Beach Neurology
West Palm Beach, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 407-500-5252
K2 Medical Research ORLANDO
Maitland, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 239-939-7777
Neuropsychiatric Research Center of Southwest Florida
Fort Myers, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 561-374-8461
Brain Matters Research
Delray Beach, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 305-933-5993
VIN - Aventura
Aventura, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 407-337-1000
Charter Research - Orlando
Orlando, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 407-916-0060
Conquest Research
Winter Park, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 813-353-9613
Axiom Brain Health LLC
Tampa, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 352-629-5800
Renstar Medical Research
Ocala, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 317-963-7402
Indiana University Health Neuroscience Center
Indianapolis, Indiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 913-574-0976
The University of Kansas - Clinical Research Center
Fairway, Kansas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 978-831-8041
Headlands Eastern MA LLC
Plymouth, Massachusetts
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 781-551-5812
Neurology Center of New England
Foxborough, Massachusetts
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 401-435-8950
K2 Medical Research - Foxborough
Foxborough, Massachusetts
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 248-957-8940
QUEST Research Institute
Farmington Hills, Michigan
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 417-328-7781
Citizens Memorial Hospital District
Bolivar, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 503-279-8252
Summit Headlands
Portland, Oregon
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 512-218-1222
Central Texas Neurology Consultants
Round Rock, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 713.790.3311
Houston Methodist Hospital
Houston, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 409-331-6040
Gadolin Research
Beaumont, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 713-486-0536
The University of Texas Health Science Center at Houston
Houston, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 703-520-9703
Re:Cognition Health
Fairfax, Virginia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 425-899-5385
EvergreenHealth
Kirkland, Washington
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓Have gradual and progressive cognitive decline for greater than or equal to ( ≥) 6 months.
- ✓Have least 1 core clinical feature of dementia with Lewy bodies (DLB).
- ✓Have a score ≥20 on Montreal Cognitive Assessment (MoCA).
- ✓Meet plasma P-tau217 criteria.
- ✓Have a cerebrospinal fluid (CSF) result consistent with the presence of brain amyloid pathology.
- ✓Have a CSF result consistent with the presence of alpha-synuclein pathology.
- ✓Have at least 1 reliable study partner who will provide written informed consent to participate, is in frequent contact with the participant, and is familiar with overall function and behavior, such as day-to-day activities and cognitive abilities.
Exclusion criteria
- ✕Have a disease or condition that could interfere with this study or is a current serious or unstable illness.
- ✕Have, or is suspected to have, a significant neurological disease (other than the studied condition) that affects the central nervous system and may affect the individual's cognition or ability to complete the study.
- ✕Have a history of cancer that, in the investigator's opinion, has a high risk of recurrence and preventing the completion of the study.
- ✕Have clinically significant multiple or severe drug allergies, significant atopy, or severe posttreatment hypersensitivity reactions.
- ✕Have previously received amyloid-targeting therapy.
- ✕Active immunization against amyloid-beta.
- ✕Have a centrally read MRI that does not meet study entry criteria.
- ✕Have contraindication to MRI or PET scans.
- ✕Have any contraindication to lumbar puncture.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.